These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20538167)

  • 1. More progression toward regression? Beyond low-density lipoprotein cholesterol lowering.
    Lewis BS; Halon DA
    J Am Coll Cardiol; 2010 Jun; 55(24):2743-4. PubMed ID: 20538167
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol.
    Bayturan O; Kapadia S; Nicholls SJ; Tuzcu EM; Shao M; Uno K; Shreevatsa A; Lavoie AJ; Wolski K; Schoenhagen P; Nissen SE
    J Am Coll Cardiol; 2010 Jun; 55(24):2736-42. PubMed ID: 20538166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose statins and atherosclerosis regression.
    von Birgelen C; Hartmann M
    JAMA; 2006 Oct; 296(15):1837; author reply 1837. PubMed ID: 17047210
    [No Abstract]   [Full Text] [Related]  

  • 4. Halting the progression of atherosclerosis with intensive lipid lowering: results from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
    Nissen SE
    Am J Med; 2005 Dec; 118 Suppl 12A():22-7. PubMed ID: 16356804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration.
    Villines TC; Stanek EJ; Devine PJ; Turco M; Miller M; Weissman NJ; Griffen L; Taylor AJ
    J Am Coll Cardiol; 2010 Jun; 55(24):2721-6. PubMed ID: 20399059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary prevention of patients with ischaemic heart disease--the reduction of LDL cholesterol level and the regression of atherosclerosis].
    Bárczi G; Merkely B
    Lege Artis Med; 2007 Oct; 17(10):675-9. PubMed ID: 19227597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons from coronary intravascular ultrasound on the importance of raising high-density lipoprotein cholesterol.
    Nicholls SJ; Uno K; Tuzcu EM; Nissen SE
    Curr Atheroscler Rep; 2010 Sep; 12(5):301-7. PubMed ID: 20628836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis.
    Chhatriwalla AK; Nicholls SJ; Wang TH; Wolski K; Sipahi I; Crowe T; Schoenhagen P; Kapadia S; Tuzcu EM; Nissen SE
    J Am Coll Cardiol; 2009 Mar; 53(13):1110-5. PubMed ID: 19324254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altering the pathophysiology of atherosclerosis: the multidimensional role of statins.
    Clearfield MB
    J Am Osteopath Assoc; 2010 Apr; 110(4 Suppl 4):S2-6. PubMed ID: 20453192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moving beyond the "LDL hypothesis".
    Werner C; Laufs U
    Vasa; 2015 Sep; 44(5):333-40. PubMed ID: 26317252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study.
    Choi SH; Chae A; Miller E; Messig M; Ntanios F; DeMaria AN; Nissen SE; Witztum JL; Tsimikas S
    J Am Coll Cardiol; 2008 Jul; 52(1):24-32. PubMed ID: 18582631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of atherosclerosis demands low LDL targets and raised HDL levels.
    Cardiovasc J Afr; 2008; 19(4):221. PubMed ID: 18776971
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipid abnormalities in women: data for risk, data for management.
    Wenger NK
    Cardiol Rev; 2006; 14(6):276-80. PubMed ID: 17053373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl.
    Posadas-Sánchez R; Posadas-Romero C; Mendoza-Pérez E; Caracas-Portilla NA; Cardoso-Saldaña G; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG
    Am J Cardiol; 2012 Mar; 109(5):636-41. PubMed ID: 22169129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
    Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction.
    Toth PP; Ballantyne CM; Davidson MH; Tomassini JE; Ramey DR; Neff D; Tershakovec AM; Hu XH; Tunceli K
    J Clin Lipidol; 2012; 6(2):180-91. PubMed ID: 22385552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between LDL, HDL, blood pressure and atheroma progression in the coronaries.
    Nicholls SJ
    Curr Opin Lipidol; 2009 Dec; 20(6):491-6. PubMed ID: 19593124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ezetimibe in the management of patients with atherosclerosis.
    Hamilton P
    Coron Artery Dis; 2009 Mar; 20(2):169-74. PubMed ID: 19106797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study on effect of quyu xiaoban capsule on regression of atherosclerosis].
    Liu YF; Zhao YX; Yu HM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jun; 25(6):499-501. PubMed ID: 16025961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.